We are introducing mitochondrial testing in early 2020 in order to increase the diagnostic yield of our neurology, cardiology, metabolic diseases, ophthalmology, and hearing loss panels.
New testing options we will offer:
- Mitochondrial genome sequencing and copy number variant analysis
- Over 30 panels updated with the whole mitochondrial genome
- Ability to customize any panel by adding individual mtDNA genes or the whole mitochondrial genome at no additional cost
If you want to hear more about the clinical significance of mitochondrial DNA testing in your medical specialty, please leave your details below and we will contact you once mitochondrial DNA testing is available.